4.7 Article

Immune receptor repertoires in pediatric and adult acute myeloid leukemia

Journal

GENOME MEDICINE
Volume 11, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13073-019-0681-3

Keywords

Acute myeloid leukemia; T cell receptor repertoires; B cell receptor repertoires; Complementarity-determining region 3

Funding

  1. NCI [U01 CA226196, U24 CA224316]
  2. National Key R&D Program of China [2017YFC0908300]
  3. CPRIT [RR170079]
  4. Chinese Scholarship Council
  5. Breast Cancer Research Foundation

Ask authors/readers for more resources

Background Acute myeloid leukemia (AML), caused by the abnormal proliferation of immature myeloid cells in the blood or bone marrow, is one of the most common hematologic malignancies. Currently, the interactions between malignant myeloid cells and the immune microenvironment, especially T cells and B cells, remain poorly characterized. Methods In this study, we systematically analyzed the T cell receptor and B cell receptor (TCR and BCR) repertoires from the RNA-seq data of 145 pediatric and 151 adult AML samples as well as 73 non-tumor peripheral blood samples. Results We inferred over 225,000 complementarity-determining region 3 (CDR3) sequences in TCR alpha, beta, gamma, and delta chains and 1,210,000 CDR3 sequences in B cell immunoglobulin (Ig) heavy and light chains. We found higher clonal expansion of both T cells and B cells in the AML microenvironment and observed many differences between pediatric and adult AML. Most notably, adult AML samples have significantly higher level of B cell activation and more secondary Ig class switch events than pediatric AML or non-tumor samples. Furthermore, adult AML with highly expanded IgA2 B cells, which might represent an immunosuppressive microenvironment, are associated with regulatory T cells and worse overall survival. Conclusions Our comprehensive characterization of the AML immune receptor repertoires improved our understanding of T cell and B cell immunity in AML, which may provide insights into immunotherapies in hematological malignancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available